Hydroxychloroquine and azithromycin, administered alone or in combiantion, are associated with potentially fatal heart disorders, according to findings of a study published in *Circulation*.

Data from the WHO pharmacovigilance database, VigiBase, prior to prescribing of hydroxychloroquine and/or azithromycin for COVID-19, were used to investigate the reporting odds ratios (RORs), and the lower end of the 95% credibility interval of the information component (IC~025~), for cardiovascular adverse drug reactions (CV-ADR) in patients who received treatment with hydroxychloroquine, azithromycin or hydroxychloroquine plus azithromycin, compared with CV-ADR reports for all other drugs in the database.

The number of CV-ADR reports identified was 76 822 in patients receiving hydroxychloroquine, 89 692 in patients receiving azithromycin, and 607 in patients receiving both hydroxychloroquine and azithromycin. Hydroxychloroquine was the suspected drug in 28.4% of cases, and azithromycin was the suspected drug in 60.8% of cases.

The reporting rate of QT interval prolongation (LQT) and/or ventricular tachycardia (VT; including torsades de pointes \[TdP\]) was 480 suspected cases for azithromycin (IC~025~ 1.67). Hydroxychloroquine was also associated with LQT and/or VT/TdP (n=136; (IC~025~ 1.04), as well as atrioventricular or bundle branch block (75; IC~025~ 1.04) and heart failure (HF; 203; IC~025~ 1.06). These drugs were not significantly associated with any other CV-ADR.

The reporting rate of LQT and/or VT/TdP was significantly greater with azithromycin than with hydroxychloroquine (0.8% vs 0.3%; ROR 2.36; 95% CI 2.05, 2.71), and was significantly greater with azithromycin plus hydroxychloroquine than with either drug alone (0.6% vs 1.5%; 95% CI 1.28, 4.79). The time to onset of LQT and/or VT/TdP was significantly shorter with azithromycin than with hydroxychloroquine (3 vs 10 days; p\<0.01).

\"Reports of potentially lethal acute cardiac proarrhythmogenic effects leading to ventricular arrhythmias have been described mainly with azithromycin but also with hydroxychloroquine. Their combination yielded an even stronger signal,\" concluded the authors. \"Hydroxychloroquine was also associated with potentially lethal HF when exposure was prolonged over several months,\" they added.
